Recce Pharmaceuticals Ltd

Informe acción ASX:RCE

Capitalización de mercado: AU$135.6m

Recce Pharmaceuticals Dirección

Dirección controles de criterios 2/4

El CEO de Recce Pharmaceuticals' es James Graham , nombrado en Aug 2020, tiene una permanencia de 3.67 años. compensación anual total es A$774.73K, compuesta por 71.1% salario y 28.9% primas, incluidas acciones y opciones de la empresa. posee directamente un 3.32% de las acciones de la empresa, por valor de A$4.63M. La antigüedad media del equipo directivo y de la junta directiva es de 3.6 años y 5.4 años, respectivamente.

Información clave

James Graham

Chief Executive Officer (CEO)

AU$774.7k

Compensación total

Porcentaje del salario del CEO71.1%
Permanencia del CEO3.8yrs
Participación del CEO3.3%
Permanencia media de la dirección3.7yrs
Promedio de permanencia en la Junta Directiva5.5yrs

Actualizaciones recientes de la dirección

We Think Shareholders Are Less Likely To Approve A Pay Rise For Recce Pharmaceuticals Ltd's (ASX:RCE) CEO For Now

Nov 01
We Think Shareholders Are Less Likely To Approve A Pay Rise For Recce Pharmaceuticals Ltd's (ASX:RCE) CEO For Now

Recent updates

We Think Shareholders Are Less Likely To Approve A Pay Rise For Recce Pharmaceuticals Ltd's (ASX:RCE) CEO For Now

Nov 01
We Think Shareholders Are Less Likely To Approve A Pay Rise For Recce Pharmaceuticals Ltd's (ASX:RCE) CEO For Now

Here's Why We're Watching Recce Pharmaceuticals' (ASX:RCE) Cash Burn Situation

Feb 13
Here's Why We're Watching Recce Pharmaceuticals' (ASX:RCE) Cash Burn Situation

We're Hopeful That Recce Pharmaceuticals (ASX:RCE) Will Use Its Cash Wisely

Jul 28
We're Hopeful That Recce Pharmaceuticals (ASX:RCE) Will Use Its Cash Wisely

Recce Pharmaceuticals (ASX:RCE) Is In A Good Position To Deliver On Growth Plans

Dec 07
Recce Pharmaceuticals (ASX:RCE) Is In A Good Position To Deliver On Growth Plans

We're Hopeful That Recce Pharmaceuticals (ASX:RCE) Will Use Its Cash Wisely

Aug 03
We're Hopeful That Recce Pharmaceuticals (ASX:RCE) Will Use Its Cash Wisely

Recce Pharmaceuticals (ASX:RCE) Is In A Good Position To Deliver On Growth Plans

Mar 08
Recce Pharmaceuticals (ASX:RCE) Is In A Good Position To Deliver On Growth Plans

Need To Know: Recce Pharmaceuticals Ltd (ASX:RCE) Insiders Have Been Selling Shares

Feb 01
Need To Know: Recce Pharmaceuticals Ltd (ASX:RCE) Insiders Have Been Selling Shares

Could The Recce Pharmaceuticals Ltd (ASX:RCE) Ownership Structure Tell Us Something Useful?

Dec 09
Could The Recce Pharmaceuticals Ltd (ASX:RCE) Ownership Structure Tell Us Something Useful?

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de James Graham en comparación con los beneficios de Recce Pharmaceuticals?
FechaCompensación totalSalarioIngresos de la empresa
Dec 31 2023n/an/a

-AU$11m

Sep 30 2023n/an/a

-AU$12m

Jun 30 2023AU$775kAU$551k

-AU$13m

Mar 31 2023n/an/a

-AU$14m

Dec 31 2022n/an/a

-AU$15m

Sep 30 2022n/an/a

-AU$13m

Jun 30 2022AU$548kAU$328k

-AU$11m

Mar 31 2022n/an/a

-AU$10m

Dec 31 2021n/an/a

-AU$8m

Sep 30 2021n/an/a

-AU$11m

Jun 30 2021AU$2mAU$294k

-AU$14m

Mar 31 2021n/an/a

-AU$13m

Dec 31 2020n/an/a

-AU$13m

Sep 30 2020n/an/a

-AU$9m

Jun 30 2020AU$216kAU$187k

-AU$4m

Mar 31 2020n/an/a

-AU$4m

Dec 31 2019n/an/a

-AU$3m

Sep 30 2019n/an/a

-AU$3m

Jun 30 2019AU$177kAU$155k

-AU$3m

Mar 31 2019n/an/a

-AU$2m

Dec 31 2018n/an/a

-AU$2m

Sep 30 2018n/an/a

-AU$2m

Jun 30 2018AU$160kAU$142k

-AU$2m

Mar 31 2018n/an/a

-AU$2m

Dec 31 2017n/an/a

-AU$3m

Sep 30 2017n/an/a

-AU$3m

Jun 30 2017AU$159kAU$145k

-AU$3m

Compensación vs. Mercado: La compensación total de James($USD504.08K) está por encima de la media de empresas de tamaño similar en el mercado Australian ($USD292.58K).

Compensación vs. Ingresos: La compensación de James ha aumentado mientras la empresa no es rentable.

CEO

James Graham

3.8yrs

Permanencia

AU$774,727

Compensación

Mr. James Hamilton-Bray Graham, B.Com. (Entrepreneurship), GAICD, serves as Chief Executive Officer at Recce Pharmaceuticals Ltd since August 28, 2020 and also serves as Managing Director since 2020. He ha...

Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
John K. Prendergast
Executive Chairman of the Board6.1yrsAU$369.85k0.15%
A$ 204.0k
James Graham
CEO, MD & Executive Director3.8yrsAU$774.73k3.32%
A$ 4.5m
Michele Diliza
Chief Scientific Director & Executive Director3.7yrsAU$539.34k1.33%
A$ 1.8m
Justin Ward
Principal Quality Chemist & Executive Directorno dataAU$306.76k0.15%
A$ 200.5k
Arthur Kollaras
Principal Engineer & Head of Manufacturingno dataAU$319.12k0.033%
A$ 44.7k
Alan Dunton
Chief Medical Advisor & Independent Non Executive Directorno dataAU$72.50k0.062%
A$ 84.3k
Justin Reynolds
Chief Financial Officer6.5yrssin datossin datos
Daniel Astudillo
Head of Marketing4.3yrssin datossin datos
Maggie Niewidok
Company Secretary1.7yrssin datossin datos

3.7yrs

Permanencia media

Equipo directivo experimentado: El equipo directivo de RCE se considera experimentado (3.6 años antigüedad media).

Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
John K. Prendergast
Executive Chairman of the Board6.1yrsAU$369.85k0.15%
A$ 204.0k
James Graham
CEO, MD & Executive Director8.9yrsAU$774.73k3.32%
A$ 4.5m
Michele Diliza
Chief Scientific Director & Executive Director8.9yrsAU$539.34k1.33%
A$ 1.8m
Justin Ward
Principal Quality Chemist & Executive Director4.8yrsAU$306.76k0.15%
A$ 200.5k
Alan Dunton
Chief Medical Advisor & Independent Non Executive Director3.8yrsAU$72.50k0.062%
A$ 84.3k
Alistair McKeough
Non-Executive Director1.7yrsAU$392.15k0.013%
A$ 17.3k

5.5yrs

Permanencia media

Junta con experiencia: La junta directiva de RCE se considera experimentada (5.4 años de antigüedad promedio).